Patent details

Basic Information

Publication number:

EP1948180

PCT Application Number:

PCT/EP/2006/068314

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP068193804

PCT Publication Number:

WO/2007/054551

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

French Title of Invention:

TRAITEMENT COMBINE DU CANCER COMPRENANT DES INHIBITEURS DE EGFR/HER2

German Title of Invention:

KOMBINATIONSBEHANDLUNG GEGEN KREBS MIT EGFR/HER2-HEMMERN

SPC Number:

Dates

Filing date:

09/11/2006

Grant date:

13/03/2013

EP Publication Date:

13/03/2013

PCT Publication Date:

18/05/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/07/2008

EP B1 Publication Date:

13/03/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/11/2026

Renunciation date:

Revocation date:

Annulment date:

Inventor

1

Name:

AMELSBERG Andree

Address:

United States (US)

2

Name:

SOLCA Flavio

Address:

Austria (AT)

3

Name:

STEHLE Gerd

Address:

Germany (DE)

4

Name:

BAUM Anke

Address:

Austria (AT)

5

Name:

VAN MEEL Jacobus C., A.

Address:

Austria (AT)

Priority

Priority Number:

05110669

Priority Date:

11/11/2005

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/517;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

19/11/2025

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages